Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Lyrica Undergoing Controlled Substance Scheduling At DEA

Jan 03 2005

• By Andrew Kasper

Related Content

Purepac, Teva Launch Neurontin Generics; Pfizer's Greenstone Unit Follows

Oct 08 2004

Pfizer's Lyrica: "Approvable" For Three Indications, But Not Generalized Anxiety

Sep 02 2004

Lilly Cymbalta Clears FDA For Diabetes-Related Neuropathic Pain After Priority Review

Sep 07 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window